Dr Daniel Podolsky

Guest Contributor
February 7, 2005

Dr Daniel Podolsky and Dr Roderick Flower have joined the board of directors of Calgary’s Antibe Therapeutics Inc, an early-stage developer of drugs for inflammatory and cardiovascular diseases. Dr Podolsky is a professor of medicine at Harvard Univ and chief of gastroenterology at Massachusetts General Hospital. He is regarded as a leading authority on inflammatory bowel disease. Dr Flower is a professor of biochemical pharmacology at the research institute of London’s Queen Mary school of medicine. He is a former principal scientist at Welcome Research Laboratories. Antibe’s research focus is on the generation of new chemical entities that improve on the parent molecules or serve unmet needs….


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.